American Institute of Mathematical Sciences

Advanced
June  2013, 18(4): 1031-1051. doi: 10.3934/dcdsb.2013.18.1031

Optimal controls for a mathematical model of tumor-immune interactions under targeted chemotherapy with immune boost

Urszula Ledzewicz 1, , Mozhdeh Sadat Faraji Mosalman 1, and  Heinz Schättler 2,

1. 

Dept. of Mathematics and Statistics, Southern Illinois University Edwardsville, Edwardsville, Illinois, 62026-1653, United States
2. 

Dept. of Electrical and Systems Engineering, Washington University, St. Louis, Missouri, 63130-4899

Received  December 2011 Revised  April 2012 Published  February 2013

An optimal control problem for combination of cancer chemotherapy with immunotherapy in form of a boost to the immune system is considered as a multi-input optimal control problem. The objective to be minimized is chosen as a weighted average of (i) the number of cancer cells at the terminal time, (ii) a measure for the immunocompetent cell densities at the terminal point (included as a negative term), the overall amounts of (iii) cytotoxic agents and (iv) immune boost given as a measure for the side effects of treatment and (v) a small penalty on the free terminal time that limits the overall therapy horizon. This last term is essential in obtaining a mathematically well-posed problem formulation. Both analytical and numerical results about the structures of optimal controls will be presented that give some insights into the structure of optimal protocols, i.e., the dose rates and sequencing of drugs in these combination treatments.
Keywords: singular controls, tumor-immune interactions, Optimal control, regions of attraction., chemotherapy.
Mathematics Subject Classification: Primary: 49K15, 92B05; Secondary: 93C9.
Citation: Urszula Ledzewicz, Mozhdeh Sadat Faraji Mosalman, Heinz Schättler. Optimal controls for a mathematical model of tumor-immune interactions under targeted chemotherapy with immune boost. Discrete & Continuous Dynamical Systems - B, 2013, 18 (4) : 1031-1051. doi: 10.3934/dcdsb.2013.18.1031
References:
[1]

D. J. Bell and D. H. Jacobson, "Singular Optimal Control Problems,", Academic Press, (1975).   Google Scholar

[2]

D. A. Benson, "A Gauss Pseudospectral Transcription for Optimal Control,", Ph.D. thesis, (2004).   Google Scholar

[3]

D. A. Benson, G. T. Huntington, T. P. Thorvaldsen and A. V. Rao, Direct trajectory optimization and costate estimation via an orthogonal collocation method,, J. of Guidance, 29 (2006), 1435.   Google Scholar

[4]

B. Bonnard and M. Chyba, "Singular Trajectories and their Role in Control Theory,", Springer Verlag, (2003).   Google Scholar

[5]

A. Bressan and B. Piccoli, "Introduction to the Mathematical Theory of Control,", American Institute of Mathematical Sciences, (2007).   Google Scholar

[6]

T. Burden, J. Ernstberger and K. R. Fister, Optimal control applied to immunotherapy, Discrete and Continuous Dynamical Systems - Series B, 4 (2004), 135.   Google Scholar

[7]

F. Castiglione and B. Piccoli, Optimal control in a model of dendritic cell transfection cancer immunotherapy,, Bulletin of Mathematical Biology, 68 (2006), 255.  doi: 10.1007/s11538-005-9014-3.  Google Scholar

[8]

M. Eisen, "Mathematical Models in Cell Biology and Cancer Chemotherapy,", Lecture Notes in Biomathematics, 30 (1979).   Google Scholar

[9]

A. Ergun, K. Camphausen and L. M. Wein, Optimal scheduling of radiotherapy and angiogenic inhibitors,, Bulletin of Mathematical Biology, 65 (2003), 407.   Google Scholar

[10]

K. R. Fister and J. Hughes Donnelly, Immunotherapy: an optimal control approach,, Mathematical Biosciences and Engineering (MBE), 2 (2005), 499.  doi: 10.3934/mbe.2005.2.499.  Google Scholar

[11]

J. Guckenheimer and P. Holmes, "Nonlinear Oscillations, Dynamical Systems, and Bifurcations of Vector Fields,", Springer Verlag, (1983).   Google Scholar

[12]

G. T. Huntington, "Advancement and Analysis of a Gauss Pseudospectral Transcription for Optimal Control,", Ph.D. thesis, (2007).   Google Scholar

[13]

D. Kirschner and J. C. Panetta, Modeling immunotherapy of the tumor-immune interaction,, J. of Mathematical Biology, 37 (1998), 235.   Google Scholar

[14]

V. A. Kuznetsov, I. A. Makalkin, M. A. Taylor and A. S. Perelson, Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis,, Bull. Mathematical Biology, 56 (1994), 295.   Google Scholar

[15]

U. Ledzewicz, J. Marriott, H. Maurer and H. Schättler, Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment,, Math. Medicine and Biology, 27 (2010), 157.  doi: 10.1093/imammb/dqp012.  Google Scholar

[16]

U. Ledzewicz, H. Maurer and H. Schättler, Bang-bang and singular controls in a mathematical model for combined anti-angiogenic and chemotherapy treatments,, Proc. 48th IEEE Conf. on Dec. and Contr., (2009), 2280.   Google Scholar

[17]

U. Ledzewicz, M. Naghnaeian and H. Schättler, An optimal control approach to cancer treatment under immunological activity,, Applicationes Mathematicae, 38 (2011), 17.  doi: 10.4064/am38-1-2.  Google Scholar

[18]

U. Ledzewicz, M. Naghnaeian and H. Schättler, Bifurcation of singular arcs in an optimal control problem for cancer immune system interactions under treatment,, Proceedings of the 49th IEEE Conf. on Decision and Control, (2010), 7039.   Google Scholar

[19]

U. Ledzewicz, M. Naghnaeian and H. Schättler, Dynamics of tumor-immune interactions under treatment as an optimal control problem,, Proc. of the 8th AIMS Conf., (2010), 971.   Google Scholar

[20]

U. Ledzewicz, M. Naghnaeian and H. Schättler, Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics,, J. of Mathematical Biology, 64 (2012), 557.  doi: 10.1007/s00285-011-0424-6.  Google Scholar

[21]

U. Ledzewicz and H. Schättler, Analysis of a cell-cycle specific model for cancer chemotherapy,, J. of Biological Systems, 10 (2002), 183.   Google Scholar

[22]

U. Ledzewicz and H. Schättler, Antiangiogenic therapy in cancer treatment as an optimal control problem,, SIAM J. Control and Optimization, 46 (2007), 1052.  doi: 10.1137/060665294.  Google Scholar

[23]

U. Ledzewicz and H. Schättler, Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis,, J. of Theoretical Biology, 252 (2008), 295.   Google Scholar

[24]

L. Norton and R. Simon, Growth curve of an experimental solid tumor following radiotherapy,, J. of the National Cancer Institute, 58 (1977), 1735.   Google Scholar

[25]

L. Norton, A Gompertzian model of human breast cancer growth,, Cancer Research, 48 (1988), 7067.   Google Scholar

[26]

A. d'Onofrio, A general framework for modeling tumor-immune system competition and immunotherapy: mathematical analysis and biomedical inferences,, Physica D, 208 (2005), 220.  doi: 10.1016/j.physd.2005.06.032.  Google Scholar

[27]

A. d'Onofrio, Tumor-immune system interaction: modeling the tumor-stimulated proliferation of effectors and immunotherapy,, Math. Models and Methods in Applied Sciences, 16 (2006), 1375.  doi: 10.1142/S0218202506001571.  Google Scholar

[28]

A. d'Onofrio, U. Ledzewicz, H. Maurer and H. Schättler, On Optimal Delivery of Combination Therapy for Tumors,, Mathematical Biosciences, 222 (2009), 13.  doi: 10.1016/j.mbs.2009.08.004.  Google Scholar

[29]

L. G. de Pillis and A. Radunskaya, A mathematical tumor model with immune resistance and drug therapy: an optimal control approach,, J. of Theoretical Medicine, 3 (2001), 79.   Google Scholar

[30]

A. V. Rao, D. A. Benson, G. T. Huntington, C. Francolin, C. L. Darby and M. A. Patterson, "User's Manual for GPOPS: A MATLAB Package for Dynamic Optimization Using the Gauss Pseudospectral Method,", University of Florida Report, (2008).   Google Scholar

[31]

H. Schättler and U. Ledzewicz, "Geometric Optimal Control: Theory, Methods and Examples,", Springer Verlag, (2012).  doi: 10.1007/978-1-4614-3834-2.  Google Scholar

[32]

N.V. Stepanova, Course of the immune reaction during the development of a malignant tumour,, Biophysics, 24 (1980), 917.   Google Scholar

[33]

G. W. Swan, Role of optimal control in cancer chemotherapy,, Mathematical Biosciences, 101 (1990), 237.   Google Scholar

[34]

A. Swierniak, Optimal treatment protocols in leukemia - modelling the proliferation cycle,, Proceedings of the 12th IMACS World Congress, 4 (1988), 170.   Google Scholar

[35]

A. Swierniak, Cell cycle as an object of control,, J. of Biological Systems, 3 (1995), 41.   Google Scholar

[36]

A. Swierniak, U. Ledzewicz and H. Schättler, Optimal control for a class of compartmental models in cancer chemotherapy,, Int. J. Applied Mathematics and Computer Science, 13 (2003), 357.   Google Scholar

[37]

H. P. de Vladar and J. A. González, Dynamic response of cancer under the influence of immunological activity and therapy,, J. of Theoretical Biology, 227 (2004), 335.  doi: 10.1016/j.jtbi.2003.11.012.  Google Scholar

show all references

References:
[1]

D. J. Bell and D. H. Jacobson, "Singular Optimal Control Problems,", Academic Press, (1975).   Google Scholar

[2]

D. A. Benson, "A Gauss Pseudospectral Transcription for Optimal Control,", Ph.D. thesis, (2004).   Google Scholar

[3]

D. A. Benson, G. T. Huntington, T. P. Thorvaldsen and A. V. Rao, Direct trajectory optimization and costate estimation via an orthogonal collocation method,, J. of Guidance, 29 (2006), 1435.   Google Scholar

[4]

B. Bonnard and M. Chyba, "Singular Trajectories and their Role in Control Theory,", Springer Verlag, (2003).   Google Scholar

[5]

A. Bressan and B. Piccoli, "Introduction to the Mathematical Theory of Control,", American Institute of Mathematical Sciences, (2007).   Google Scholar

[6]

T. Burden, J. Ernstberger and K. R. Fister, Optimal control applied to immunotherapy, Discrete and Continuous Dynamical Systems - Series B, 4 (2004), 135.   Google Scholar

[7]

F. Castiglione and B. Piccoli, Optimal control in a model of dendritic cell transfection cancer immunotherapy,, Bulletin of Mathematical Biology, 68 (2006), 255.  doi: 10.1007/s11538-005-9014-3.  Google Scholar

[8]

M. Eisen, "Mathematical Models in Cell Biology and Cancer Chemotherapy,", Lecture Notes in Biomathematics, 30 (1979).   Google Scholar

[9]

A. Ergun, K. Camphausen and L. M. Wein, Optimal scheduling of radiotherapy and angiogenic inhibitors,, Bulletin of Mathematical Biology, 65 (2003), 407.   Google Scholar

[10]

K. R. Fister and J. Hughes Donnelly, Immunotherapy: an optimal control approach,, Mathematical Biosciences and Engineering (MBE), 2 (2005), 499.  doi: 10.3934/mbe.2005.2.499.  Google Scholar

[11]

J. Guckenheimer and P. Holmes, "Nonlinear Oscillations, Dynamical Systems, and Bifurcations of Vector Fields,", Springer Verlag, (1983).   Google Scholar

[12]

G. T. Huntington, "Advancement and Analysis of a Gauss Pseudospectral Transcription for Optimal Control,", Ph.D. thesis, (2007).   Google Scholar

[13]

D. Kirschner and J. C. Panetta, Modeling immunotherapy of the tumor-immune interaction,, J. of Mathematical Biology, 37 (1998), 235.   Google Scholar

[14]

V. A. Kuznetsov, I. A. Makalkin, M. A. Taylor and A. S. Perelson, Nonlinear dynamics of immunogenic tumors: parameter estimation and global bifurcation analysis,, Bull. Mathematical Biology, 56 (1994), 295.   Google Scholar

[15]

U. Ledzewicz, J. Marriott, H. Maurer and H. Schättler, Realizable protocols for optimal administration of drugs in mathematical models for anti-angiogenic treatment,, Math. Medicine and Biology, 27 (2010), 157.  doi: 10.1093/imammb/dqp012.  Google Scholar

[16]

U. Ledzewicz, H. Maurer and H. Schättler, Bang-bang and singular controls in a mathematical model for combined anti-angiogenic and chemotherapy treatments,, Proc. 48th IEEE Conf. on Dec. and Contr., (2009), 2280.   Google Scholar

[17]

U. Ledzewicz, M. Naghnaeian and H. Schättler, An optimal control approach to cancer treatment under immunological activity,, Applicationes Mathematicae, 38 (2011), 17.  doi: 10.4064/am38-1-2.  Google Scholar

[18]

U. Ledzewicz, M. Naghnaeian and H. Schättler, Bifurcation of singular arcs in an optimal control problem for cancer immune system interactions under treatment,, Proceedings of the 49th IEEE Conf. on Decision and Control, (2010), 7039.   Google Scholar

[19]

U. Ledzewicz, M. Naghnaeian and H. Schättler, Dynamics of tumor-immune interactions under treatment as an optimal control problem,, Proc. of the 8th AIMS Conf., (2010), 971.   Google Scholar

[20]

U. Ledzewicz, M. Naghnaeian and H. Schättler, Optimal response to chemotherapy for a mathematical model of tumor-immune dynamics,, J. of Mathematical Biology, 64 (2012), 557.  doi: 10.1007/s00285-011-0424-6.  Google Scholar

[21]

U. Ledzewicz and H. Schättler, Analysis of a cell-cycle specific model for cancer chemotherapy,, J. of Biological Systems, 10 (2002), 183.   Google Scholar

[22]

U. Ledzewicz and H. Schättler, Antiangiogenic therapy in cancer treatment as an optimal control problem,, SIAM J. Control and Optimization, 46 (2007), 1052.  doi: 10.1137/060665294.  Google Scholar

[23]

U. Ledzewicz and H. Schättler, Optimal and suboptimal protocols for a class of mathematical models of tumor anti-angiogenesis,, J. of Theoretical Biology, 252 (2008), 295.   Google Scholar

[24]

L. Norton and R. Simon, Growth curve of an experimental solid tumor following radiotherapy,, J. of the National Cancer Institute, 58 (1977), 1735.   Google Scholar

[25]

L. Norton, A Gompertzian model of human breast cancer growth,, Cancer Research, 48 (1988), 7067.   Google Scholar

[26]

A. d'Onofrio, A general framework for modeling tumor-immune system competition and immunotherapy: mathematical analysis and biomedical inferences,, Physica D, 208 (2005), 220.  doi: 10.1016/j.physd.2005.06.032.  Google Scholar

[27]

A. d'Onofrio, Tumor-immune system interaction: modeling the tumor-stimulated proliferation of effectors and immunotherapy,, Math. Models and Methods in Applied Sciences, 16 (2006), 1375.  doi: 10.1142/S0218202506001571.  Google Scholar

[28]

A. d'Onofrio, U. Ledzewicz, H. Maurer and H. Schättler, On Optimal Delivery of Combination Therapy for Tumors,, Mathematical Biosciences, 222 (2009), 13.  doi: 10.1016/j.mbs.2009.08.004.  Google Scholar

[29]

L. G. de Pillis and A. Radunskaya, A mathematical tumor model with immune resistance and drug therapy: an optimal control approach,, J. of Theoretical Medicine, 3 (2001), 79.   Google Scholar

[30]

A. V. Rao, D. A. Benson, G. T. Huntington, C. Francolin, C. L. Darby and M. A. Patterson, "User's Manual for GPOPS: A MATLAB Package for Dynamic Optimization Using the Gauss Pseudospectral Method,", University of Florida Report, (2008).   Google Scholar

[31]

H. Schättler and U. Ledzewicz, "Geometric Optimal Control: Theory, Methods and Examples,", Springer Verlag, (2012).  doi: 10.1007/978-1-4614-3834-2.  Google Scholar

[32]

N.V. Stepanova, Course of the immune reaction during the development of a malignant tumour,, Biophysics, 24 (1980), 917.   Google Scholar

[33]

G. W. Swan, Role of optimal control in cancer chemotherapy,, Mathematical Biosciences, 101 (1990), 237.   Google Scholar

[34]

A. Swierniak, Optimal treatment protocols in leukemia - modelling the proliferation cycle,, Proceedings of the 12th IMACS World Congress, 4 (1988), 170.   Google Scholar

[35]

A. Swierniak, Cell cycle as an object of control,, J. of Biological Systems, 3 (1995), 41.   Google Scholar

[36]

A. Swierniak, U. Ledzewicz and H. Schättler, Optimal control for a class of compartmental models in cancer chemotherapy,, Int. J. Applied Mathematics and Computer Science, 13 (2003), 357.   Google Scholar

[37]

H. P. de Vladar and J. A. González, Dynamic response of cancer under the influence of immunological activity and therapy,, J. of Theoretical Biology, 227 (2004), 335.  doi: 10.1016/j.jtbi.2003.11.012.  Google Scholar

[1]

Urszula Ledzewicz, Omeiza Olumoye, Heinz Schättler. On optimal chemotherapy with a strongly targeted agent for a model of tumor-immune system interactions with generalized logistic growth. Mathematical Biosciences & Engineering, 2013, 10 (3) : 787-802. doi: 10.3934/mbe.2013.10.787
[2]

Urszula Ledzewicz, Mohammad Naghnaeian, Heinz Schättler. Dynamics of tumor-immune interaction under treatment as an optimal control problem. Conference Publications, 2011, 2011 (Special) : 971-980. doi: 10.3934/proc.2011.2011.971
[3]

Shujing Shi, Jicai Huang, Yang Kuang. Global dynamics in a tumor-immune model with an immune checkpoint inhibitor. Discrete & Continuous Dynamical Systems - B, 2017, 22 (11) : 0-0. doi: 10.3934/dcdsb.2020157
[4]

Shuo Wang, Heinz Schättler. Optimal control of a mathematical model for cancer chemotherapy under tumor heterogeneity. Mathematical Biosciences & Engineering, 2016, 13 (6) : 1223-1240. doi: 10.3934/mbe.2016040
[5]

Dan Liu, Shigui Ruan, Deming Zhu. Bifurcation analysis in models of tumor and immune system interactions. Discrete & Continuous Dynamical Systems - B, 2009, 12 (1) : 151-168. doi: 10.3934/dcdsb.2009.12.151
[6]

Giulio Caravagna, Alex Graudenzi, Alberto d’Onofrio. Distributed delays in a hybrid model of tumor-Immune system interplay. Mathematical Biosciences & Engineering, 2013, 10 (1) : 37-57. doi: 10.3934/mbe.2013.10.37
[7]

J.C. Arciero, T.L. Jackson, D.E. Kirschner. A mathematical model of tumor-immune evasion and siRNA treatment. Discrete & Continuous Dynamical Systems - B, 2004, 4 (1) : 39-58. doi: 10.3934/dcdsb.2004.4.39
[8]

Mohammad A. Tabatabai, Wayne M. Eby, Karan P. Singh, Sejong Bae. T model of growth and its application in systems of tumor-immune dynamics. Mathematical Biosciences & Engineering, 2013, 10 (3) : 925-938. doi: 10.3934/mbe.2013.10.925
[9]

Lifeng Han, Changhan He, Yang Kuang. Dynamics of a model of tumor-immune interaction with time delay and noise. Discrete & Continuous Dynamical Systems - S, 2018, 0 (0) : 0-0. doi: 10.3934/dcdss.2020140
[10]

Shuo Wang, Heinz Schättler. Optimal control for cancer chemotherapy under tumor heterogeneity with Michealis-Menten pharmacodynamics. Discrete & Continuous Dynamical Systems - B, 2019, 24 (5) : 2383-2405. doi: 10.3934/dcdsb.2019100
[11]

Arturo Alvarez-Arenas, Konstantin E. Starkov, Gabriel F. Calvo, Juan Belmonte-Beitia. Ultimate dynamics and optimal control of a multi-compartment model of tumor resistance to chemotherapy. Discrete & Continuous Dynamical Systems - B, 2019, 24 (5) : 2017-2038. doi: 10.3934/dcdsb.2019082
[12]

Urszula Ledzewicz, Heinz Schättler, Shuo Wang. On the role of tumor heterogeneity for optimal cancer chemotherapy. Networks & Heterogeneous Media, 2019, 14 (1) : 131-147. doi: 10.3934/nhm.2019007
[13]

Martina Conte, Maria Groppi, Giampiero Spiga. Qualitative analysis of kinetic-based models for tumor-immune system interaction. Discrete & Continuous Dynamical Systems - B, 2018, 23 (6) : 2393-2414. doi: 10.3934/dcdsb.2018060
[14]

Min Yu, Gang Huang, Yueping Dong, Yasuhiro Takeuchi. Complicated dynamics of tumor-immune system interaction model with distributed time delay. Discrete & Continuous Dynamical Systems - B, 2020, 25 (7) : 2391-2406. doi: 10.3934/dcdsb.2020015
[15]

Wei Feng, Shuhua Hu, Xin Lu. Optimal controls for a 3-compartment model for cancer chemotherapy with quadratic objective. Conference Publications, 2003, 2003 (Special) : 544-553. doi: 10.3934/proc.2003.2003.544
[16]

Urszula Ledzewicz, Heinz Schättler. The Influence of PK/PD on the Structure of Optimal Controls in Cancer Chemotherapy Models. Mathematical Biosciences & Engineering, 2005, 2 (3) : 561-578. doi: 10.3934/mbe.2005.2.561
[17]

Urszula Ledzewicz, Heinz Schättler. On the optimality of singular controls for a class of mathematical models for tumor anti-angiogenesis. Discrete & Continuous Dynamical Systems - B, 2009, 11 (3) : 691-715. doi: 10.3934/dcdsb.2009.11.691
[18]

Urszula Ledzewicz, Heinz Schättler. Drug resistance in cancer chemotherapy as an optimal control problem. Discrete & Continuous Dynamical Systems - B, 2006, 6 (1) : 129-150. doi: 10.3934/dcdsb.2006.6.129
[19]

Craig Collins, K. Renee Fister, Bethany Key, Mary Williams. Blasting neuroblastoma using optimal control of chemotherapy. Mathematical Biosciences & Engineering, 2009, 6 (3) : 451-467. doi: 10.3934/mbe.2009.6.451
[20]

Dan Liu, Shigui Ruan, Deming Zhu. Stable periodic oscillations in a two-stage cancer model of tumor and immune system interactions. Mathematical Biosciences & Engineering, 2012, 9 (2) : 347-368. doi: 10.3934/mbe.2012.9.347

2018 Impact Factor: 1.008

Tools

Metrics

  • PDF downloads (120)
  • HTML views (0)
  • Cited by (11)

Other articles
by authors

[Back to Top]

Copyright © 2020 American Institute of Mathematical Sciences